Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening
Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening
批准号:
10548889
负责人:
Laura D. Scherer
金额:
$62.17万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-01 至 2026-01-31
关键词:
AffectiveAgeAgreementAppointmentAttitudeBehavioral SciencesBreast Cancer DetectionCognitiveCommunicationDecision AidDecision MakingDiagnosisEnvironmentEquilibriumEvaluationFamilyFeelingFocus GroupsFriendsFrightFutureGuidelinesHarm ReductionHealthHealth Care RationingInterviewKnowledgeLongitudinal StudiesLongitudinal SurveysMammographic screeningMammographyMedicalPatientsPersonsPopulationPrevalencePrimary CareProbabilityRandomizedReactionRecommendationResearchRiskScreening for cancerSocial EnvironmentSourceSuggestionSurveysTelephoneTestingTimeTrustUnited States Preventative Services Task ForceWomanage groupcancer riskcomorbiditycopingdistrustempowermentexpectationfollow-upimprovedinsightinterestovertreatmentpersonalized approachpilot testpredicting responsepreferenceprimary care providerresponsescreeningscreening guidelinesshared decision makingsocialtheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Cancer screening for the right patients at the right level of cancer risk can save lives, but over the last several
years many expert groups have de-intensified mammography screening recommendations because of
evidence of net harm for certain populations. Newer recommendations for mammography screening highlight a
tailored approach based on age and risk and comorbidities, aiming to minimize harms and reach women who
could benefit the most. For example, according to the United States Preventive Services Task Force
guidelines, women age 40-49 should talk with their doctor and make an informed choice about whether to
initiate screening. The change in emphasis from strongly promoting annual mammograms for all women over
40 to promoting informed choice in this age group constitutes a medical reversal, in the sense that this new
message is very different from past messages and people’s expectations. Moreover, the recommendation for
informed choice can elicit negative reactions in some women. Many women express disbelief when told about
overdiagnosis and overtreatment, which are significant harms of screening. The notion of risk-based
screening—that is, creating a screening plan tailored to a woman’s objective cancer risk—can raise suspicions
of healthcare rationing. The result is a delicate situation in which there is need to convey the evidence to
women so they can make an informed choice, but also a need to do it in a way that maintains credibility and
trust despite this health message reversal. In this research we focus on four types of concerning responses
that women may express in reaction to mammography evidence: Reactance (i.e. perceived manipulation or
influence, e.g. “this is trying to ration healthcare”), self-Exemption (e.g., “this doesn’t apply to me”), Disbelief
(e.g., “you can’t believe all the research anyway”), and Source derogation (e.g., “I don’t trust this source”),
which we shorten to REDS. This research will identify affective and cognitive predictors of these reactions, and
identify the consequences of these reactions for screening preferences and shared decision-making. In Aim 1
we will conduct a nationally representative survey of women age 40-49 and test affective and cognitive
predictors of REDS reactions and consequences for screening intentions. In Aim 2 we will conduct a
longitudinal survey and identify how women’s attitudes toward the evidence predicts shared decision making
for mammography in an upcoming primary care appointment, and we will also examine how these attitudes
change over time and are influence by women’s broader social environment. In Aim 3, we will conduct
interviews and focus groups to identify strategies for communicating more effectively about screening, to avoid
negative REDS responses, and promote positive responses like empowerment and desire for shared decision
making. We will modify an existing mammography decision aid to incorporate these improvements, and then
conduct randomized pilot tests of these improvements to provide preliminary evidence that they reduce REDS
and improve women’s positive responses to mammography evidence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding and addressing rejection of personalized cancer risk information
-
批准号:10639183
-
项目类别:
-
资助金额:$66.05万
-
财政年份:2023
-
负责人:Laura D. Scherer
-
依托单位:
Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening
-
批准号:10330447
-
项目类别:
-
资助金额:$63.94万
-
财政年份:2021
-
负责人:Laura D. Scherer
-
依托单位:
Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening
-
批准号:10097346
-
项目类别:
-
资助金额:$66.37万
-
财政年份:2021
-
负责人:Laura D. Scherer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: